verapamil and epirubicin

verapamil has been researched along with epirubicin in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.44)	18.7374
1990's	29 (70.73)	18.2507
2000's	8 (19.51)	29.6817
2010's	3 (7.32)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Belov, L; Davey, MW; Davey, RA; Kidman, AD; Marks, DC	1
Djaldetti, M; Gilgal, R; Klein, B; Sheinberg, A; Zahavi, I	1
Endresen, L; Hall, KS; Rugstad, HE	1
Gisslinger, H; Ludwig, H; Pirker, R; Wallner, J; Watzke, H	1
Hellström, P; Kontturi, M; Lukkarinen, O; Nurmi, M; Ottelin, J; Paul, C; Puntala, P; Tammela, T; Tidefeldt, U	1
Cairo, MS; Sender, L; Toy, C; van de Ven, C	1
Bedenne, L; Caillot, D; Chauffert, B; Corda, C; Martin, F; Pelletier, H; Solary, E	1
Hossfeld, DK; Jonat, W; Langenbuch, T; Mross, K	1
Balli, M; Bandello, A; Bonciarelli, G; Demicheli, R; Jirillo, A; Lonardi, F	1
Davey, MW; Davey, RA; Kidman, AD; Marks, DC	2
Di Simone, D; Grassi, B; Malvaldi, G; Mattii, L; Petrini, M; Testi, R; Zaccaro, L	1
Belov, L; Davey, MW; Davey, RA; Hancox, D; Harvie, RM; Longhurst, TJ; Wheeler, H	1
Davey, MW; Davey, RA; Kidman, AD; Su, GM	1
Chen, WY; Hu, X	1
Bicknell, SR; Hamilton, T; Kaye, SB; Morrison, JG; Plumb, JA; Setanoians, A; Wishart, GC	1
Czejka, M; Scheithauer, W; Schenk, T	1
Hamm, K; Hossfeld, DK; Mross, K	1
Bohn, C; Edler, L; Goebel, M; Heidemann, E; Hossfeld, DK; Jonat, W; Mross, K; Queisser, W	1
Czejka, MJ; Scheithauer, W; Schenk, T	1
Hasegawa, S; Koga, H; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A	1
Globits, S; Kornek, G; Pidlich, J; Raderer, M; Scheithauer, W; Schenk, T; Schulz, F; Tetzner, C	1
Gastl, G; Greiner, J; Hartlapp, J; Kröger, N; Kupper, H; Mross, K; Schernhammer, E; Schüller, J; Schumacher, K; Thürlimann, B	1
Karner, J; Kastner, J; Koperna-Mach, K; Kornek, G; Müller, C; Raderer, M; Scheithauer, W; Tetzner, C	1
Cooper, A; Duffy, PM; Hayes, MC; Smart, CJ	1
Cooper, A; Duffy, PM; Gatrell, SK; Hayes, MC; Smart, CJ	1
Timcheva, CV; Todorov, DK	1
Kroeger, N; Kupper, H; Lehnert, M; Mross, K; Schueller, J; Thuerlimann, B	1
Andrulis, I; Blackstein, M; Franssen, E; Fraser, RA; Goss, PE; Hedley, D; Hill, W; Kates, R; Knight, S; Myers, R; Oldfield, S; Pritchard, KI; Roche, K; Trudeau, M; Warner, E; Warr, D; Webster, S	1
deSilva, M; El-Osta, A; Hu, XF; Kantharidis, P; Nadalin, G; Parkin, JD; Slater, A; Wall, DM; Zalcberg, JR	1
Lankelma, J; Westerhoff, HV; Wielinga, PR	1
Anderson, WR; Cooper, AJ; Crook, TJ; Duffy, PM; Harris, NM; Hayes, MC; Sharpe, P; Solomon, LZ	1
Burgués, JP; Gómez, L; Jiménez-Cruz, JF; Ozonas, M; Pontones, JL; Vera, CD	1
Arimori, K; Hidaka, M; Ichihara, E; Iwakiri, T; Kawano, Y; Kumagai, Y; Okumura, M	1
Bailey, JG; Coyne, CP; Ross, MK	1
Birch, BR; Cooper, AJ; Featherstone, JM; Hayes, MC; Lwaleed, BA; Speers, AG	1
Aukerman, SL; Chello, M; Covino, E; Menna, P; Minotti, G; Salvatorelli, E; Sung, V; Surapaneni, S	1

Reviews

1 review(s) available for verapamil and epirubicin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

8 trial(s) available for verapamil and epirubicin

Article	Year
Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours. Scandinavian journal of urology and nephrology, 1991, Volume: 25, Issue:1 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Drug Synergism; Electrocoagulation; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Verapamil	1991
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Prognosis; Survival Rate; Verapamil	1993
Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma. Cancer, 1995, Oct-15, Volume: 76, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome; Verapamil	1995
Dexverapamil to overcome epirubicin resistance in advanced breast cancer. Journal of cancer research and clinical oncology, 1995, Volume: 121 Suppl 3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcium Channel Blockers; Drug Resistance; Epirubicin; Female; Humans; Middle Aged; Verapamil	1995
Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. Journal of cancer research and clinical oncology, 1995, Volume: 121 Suppl 3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Drug Resistance, Multiple; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Pancreatic Neoplasms; Verapamil	1995
Does verapamil help overcome multidrug resistance in tumor cell lines and cancer patients? Journal of chemotherapy (Florence, Italy), 1996, Volume: 8, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Calcium Channel Blockers; Cell Division; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Female; Humans; Middle Aged; Tumor Cells, Cultured; Verapamil	1996
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer. British journal of cancer, 1998, Volume: 77, Issue:7 Topics: Adult; Aged; Antibiotics, Antineoplastic; Blood Pressure; Breast Neoplasms; Calcium Channel Blockers; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoplasm Invasiveness; Treatment Outcome; Verapamil	1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Verapamil	1998

Other Studies

32 other study(ies) available for verapamil and epirubicin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leukemia research, 1992, Volume: 16, Issue:12 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Coloring Agents; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Epirubicin; Humans; Membrane Glycoproteins; Tetrazolium Salts; Thiazoles; Trypan Blue; Verapamil; Vinblastine	1992
Effect of anthracycline drugs on the element content of cultured embryonic rat cardiomyocytes. Arzneimittel-Forschung, 1991, Volume: 41, Issue:11 Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Calcium Radioisotopes; Cells, Cultured; Doxorubicin; Elements; Epirubicin; Female; Heart; Microchemistry; Mitoxantrone; Myocardium; Pregnancy; Rats; Rats, Inbred Strains; Verapamil; X-Ray Diffraction	1991
Verapamil potentiates 4'-epidoxorubicin cytotoxicity in a rat hepatoma cell line and in a substrain resistant to 4'-epidoxorubicin. Pharmacology & toxicology, 1990, Volume: 67, Issue:5 Topics: Animals; Carcinoma, Hepatocellular; Cell Survival; Drug Resistance; Drug Synergism; Epirubicin; Liver Neoplasms, Experimental; Rats; Tumor Cells, Cultured; Verapamil	1990
Effect of combination chemotherapy with verapamil. Lancet (London, England), 1990, Oct-27, Volume: 336, Issue:8722 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Hodgkin Disease; Humans; Male; RNA, Neoplasm; Verapamil	1990
Effect of idarubicin and epirubicin on in vitro polymorphonuclear function: diminished superoxide radical formation compared to their parent compounds daunorubicin and doxorubicin. Journal of leukocyte biology, 1990, Volume: 47, Issue:3 Topics: Cyclosporins; Daunorubicin; Doxorubicin; Epirubicin; Free Radicals; Humans; Idarubicin; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protein Kinase C; Superoxides; Verapamil	1990
Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice. British journal of cancer, 1990, Volume: 62, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Colonic Neoplasms; Drug Resistance; Drug Synergism; Epirubicin; In Vitro Techniques; Quinidine; Quinine; Rats; Verapamil	1990
A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer. Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Epirubicin; Female; Humans; Ifosfamide; Middle Aged; Verapamil	1990
4'epidoxorubicin plus verapamil in anthracycline--refractory cancer patients. Tumori, 1989, Jun-30, Volume: 75, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pilot Projects; Thyroid Neoplasms; Verapamil	1989
Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line. Biochemical pharmacology, 1995, Aug-08, Volume: 50, Issue:4 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Butyrates; Butyric Acid; Cell Differentiation; Cell Survival; Colchicine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia; Phenotype; Rhodamine 123; Rhodamines; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Verapamil	1995
Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines. Leukemia research, 1995, Volume: 19, Issue:4 Topics: Animals; Biological Transport; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Idarubicin; In Vitro Techniques; Leukemia P388; Mice; Mitoxantrone; Tumor Cells, Cultured; Verapamil	1995
Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leukemia research, 1995, Volume: 19, Issue:4 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Buthionine Sulfoximine; Cell Line; Cell Survival; Drug Resistance, Multiple; Epirubicin; Gene Expression; Humans; In Vitro Techniques; Methionine Sulfoximine; Multidrug Resistance-Associated Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Verapamil	1995
Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. British journal of haematology, 1994, Volume: 88, Issue:3 Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Methionine Sulfoximine; Tretinoin; Tumor Cells, Cultured; Verapamil; Vinblastine	1994
[Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r]. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1994, Volume: 15, Issue:3 Topics: Antibiotics, Antineoplastic; Cell Nucleus; Chromatography, High Pressure Liquid; Cytoplasm; Daunorubicin; Doxorubicin; Drug Resistance; Epirubicin; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured; Verapamil	1994
Differentiation and multidrug resistance in response to drug treatment in the K562 human leukaemia cell line. British journal of haematology, 1993, Volume: 84, Issue:1 Topics: Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carrier Proteins; Cell Differentiation; Drug Resistance; Epirubicin; Humans; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine	1993
Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft. Biochemical pharmacology, 1994, Jan-20, Volume: 47, Issue:2 Topics: Animals; Calcium Channel Blockers; Doxorubicin; Drug Resistance; Drug Synergism; Epirubicin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Propylamines; Quinidine; Tumor Cells, Cultured; Verapamil	1994
Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil. British journal of cancer, 1993, Volume: 68, Issue:1 Topics: Colonic Neoplasms; Drug Resistance; Epirubicin; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Rectal Neoplasms; Verapamil	1993
Effects of verapamil on the pharmacokinetics and metabolism of epirubicin. Cancer chemotherapy and pharmacology, 1993, Volume: 31, Issue:5 Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Glucuronates; Humans; Verapamil	1993
[The combination of epirubicin with d-verapamil and/or tamoxifen in cell cultures]. Die Pharmazie, 1993, Volume: 48, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Screening Assays, Antitumor; Epirubicin; Tamoxifen; Tumor Cells, Cultured; Verapamil	1993
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line. Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:11 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Transitional Cell; Cisplatin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Humans; Mitomycin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil; Vinca Alkaloids	1995
Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model. British journal of urology, 1996, Volume: 77, Issue:6 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorescence; Humans; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil	1996
Determination and reversal of resistance to epirubicin intravesical chemotherapy. A confocal imaging study. British journal of urology, 1996, Volume: 77, Issue:6 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorescence; Humans; Microscopy, Confocal; Sensitivity and Specificity; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil	1996
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:11 Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Blotting, Southern; Daunorubicin; Decitabine; Dinucleoside Phosphates; DNA Methylation; Drug Resistance, Multiple; Epirubicin; Exons; Humans; Introns; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Promoter Regions, Genetic; Restriction Mapping; Transcription, Genetic; Tumor Cells, Cultured; Verapamil	1997
The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells. European journal of biochemistry, 2000, Volume: 267, Issue:3 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Biological Transport, Active; Cell Compartmentation; Cell Line; Cell Membrane Permeability; Daunorubicin; Digitonin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Idarubicin; Kinetics; Verapamil	2000
Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer. BJU international, 2002, Volume: 90, Issue:9 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms; Verapamil	2002
A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids. European urology, 2007, Volume: 51, Issue:4 Topics: Antineoplastic Agents; Ciprofloxacin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Spheroids, Cellular; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil	2007
Inhibition of carrier-mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes. Journal of applied toxicology : JAT, 2008, Volume: 28, Issue:3 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Antibiotics, Antineoplastic; Biological Transport, Active; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carrier Proteins; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Antagonism; Epirubicin; Gene Expression Regulation; Hepatocytes; Male; Nitriles; p-Aminohippuric Acid; Rats; Rats, Wistar; Rotenone; Sodium Azide; Uncoupling Agents; Verapamil	2008
Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition. Journal of drug targeting, 2009, Volume: 17, Issue:6 Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Drug Resistance, Neoplasm; Epirubicin; ErbB Receptors; Female; Humans; Immunoconjugates; Immunoglobulin G; Receptor, ErbB-2; Verapamil	2009
Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines. Urology, 2009, Volume: 74, Issue:2 Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Flow Cytometry; Humans; Microscopy, Confocal; Urinary Bladder Neoplasms; Verapamil	2009
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. I. Amrubicin accumulates to a lower level than doxorubicin or epirubicin. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Epirubicin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Myocardium; Verapamil	2012

chemdatabank.com